Contec Medical Systems Co

Contec Medical Systems Co ROE

The Return on Equity (ROE) of Contec Medical Systems Co (300869.SZ) as of Oct 8, 2026 is -1.41 %. In the previous year, Return on Equity (ROE) was -4.19 % — a change of -66.40% (higher).

ROE

-1.41 %

YoY

-66.40%

Last updated:

In 2025, Contec Medical Systems Co's return on equity (ROE) was -1.41 %, a -66.40% increase from the -4.19 % ROE in the previous year.

The Contec Medical Systems Co ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
12.18 CNY
Jan 1, 2019
12.65 CNY
Jan 1, 2020
39.10 CNY
Jan 1, 2021
19.36 CNY
Jan 1, 2022
10.17 CNY
Jan 1, 2023
8.11 CNY
Jan 1, 2024
-4.19 CNY
Jan 1, 2025
-1.41 CNY
The Contec Medical Systems Co ROE history
YEARROEYoY
-1.41 %-66.40%
-4.19 %-151.74%
8.11 %-20.32%
10.17 %-47.44%
19.36 %-50.49%
39.10 %+209.07%
12.65 %+3.85%
12.18 %-29.42%
17.26 %-38.13%
27.89 %+32.95%
20.98 %-11.78%
23.78 %—
Access this data via the Eulerpool API
Get Free API Key

Contec Medical Systems Co Stock analysis

What does Contec Medical Systems Co do? Contec Medical Systems Co is one of the most popular companies on Eulerpool.

ROE Details

Decoding Contec Medical Systems Co's Return on Equity (ROE)

Contec Medical Systems Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Contec Medical Systems Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Contec Medical Systems Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Contec Medical Systems Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Contec Medical Systems Co stock

Return on Equity (ROE) of Contec Medical Systems Co is -1.41 % in 2025.

Return on Equity (ROE) of Contec Medical Systems Co changed from -4.19 % to -1.41 %, representing a -66.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Contec Medical Systems Co since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Contec Medical Systems Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API
Get Free API Key

Profitability — Contec Medical Systems Co

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Contec Medical Systems Co